Cyprotex sees profits down in H1, but predicts US growth
Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs